The Americans approved a slimming drug. A breakthrough in the treatment of obesity?

The US Food and Drug Administration (FDA) has just approved a slimming drug. It gives effects that could only be achieved operationally in the past, boast its creators.

1. Scientists compare the effectiveness of the drug with the effects of surgery
2. The drug has been on the market for several years as a drug for diabetes, and its therapeutic side effect has now been confirmed
3. Wegovy – because we are talking about it – is made by the Danish pharmaceutical company Novo Nordisk and is the first FDA-approved weight loss drug since 2014.
4. The price may be an obstacle to the use of the drug on a large scale
5. More information can be found on the Onet homepage

Antidiabetic drug in the fight against obesity

No other drug comes even close to Wegovy’s effectiveness in weight loss – a real breakthrough, says obesity researcher Rachel Batterham of University College London. – For the first time, we can achieve with drugs what was possible only thanks to surgery – he emphasizes.

Wegovy, a weight loss therapy produced by the Danish pharmaceutical company Novo Nordisk, is the first FDA-approved weight loss drug since 2014, although it has already functioned as an anti-diabetes drug. Diabetes, due to the scale of the problem, is a civilization disease of the contemporary consumer society and therefore has become a field for many studies – many anti-diabetic drugs with different mechanisms of action are being created.

1. Also read: Diabetes – types, causes, symptoms, treatment [EXPLAINED]

Wegovy, called Semaglutide, has been used for years in the United States and elsewhere, and it has recently been discovered and confirmed by research to act as a powerful and effective appetite suppressant when the dose is changed. There are many drugs whose target effect has been taken as a side effect. Viagra, for example, was developed in a similar way as a cure for pulmonary hypertension and only later discovered its potential for treating erectile dysfunction. Modafinil, on the other hand, was a drug for narcolepsy to become a remedy for people who need to stay focused for a long time – such as shift work, hospital duty or plane flights.

Obesity Drug: Mechanism of Action

The FDA announced that Wegovy has been approved for long-term weight management in obese or overweight adults who also have an obesity-related condition (such as hypertension, type 2 diabetes or high cholesterol).

The therapy, to be launched by Novo Nordisk in the US later this month, is in the form of an injection, taken once a week. The drug provides the hormone glucagon-like peptide-1 (GLP-1), which is responsible for the feeling of satiety and thus helps to control the appetite.

1. Ranking of weight loss supplements – which weight loss pills should you choose?

Wegovy’s Obesity: Research

In the first study, published this year, involving nearly 2000 obese adults from 16 different countries showed an average of almost 15 percent. weight loss in the whole group. Some respondents lost even more, and more than 30 percent. groups lost more than 20 percent. body weight.

The FDA has now considered the results of four independent clinical trials that lasted 68 weeks and included a total of around 4500 patients who were randomized to receive either Wegovy or placebo. Average weight loss ranged from 17 to 18 percent. and persisted throughout the tests. The subjects who took Wegovy also reduced the caloric content of their meals and increased their physical activity. Only 2,4 percent were reported in the placebo group. weight loss under identical conditions.

The side effects that subjects reported were mild to moderate and included nausea, diarrhea, vomiting, constipation, and abdominal pain.

1. Also read: 10 ways to lose weight healthy – how to lose weight wisely?

Scientists confirm results never before achieved with anti-obesity drugs. Wegovy could actually change the lives of many people, because overweight and obesity is a civilization problem not only in the United States. Financial issues may prove to be a barrier. Although Novo Nordisk has yet to confirm the price of the drug, we already know the leaks that the cost of therapy could be around $ 1300 per month.

If you want to support your body in the fight against obesity, reach for Obesity – a mixture of herbs available at a promotional price on Medonet Market.

Read also:

1. Ewa Chodakowska’s new mission. “I want to start the young generation”
2. 10 serious diseases that obesity can cause. Some are surprising
3. 90 percent COVID-19 deaths occur in countries with a high percentage of overweight people
4. How to refuse a child who is begging for a candy bar? Nutritionist advises